Accès public

Autoantibodies against type I IFNs in patients with life-threatening COVID-19

P Bastard, LB Rosen, Q Zhang, E Michailidis, HH Hoffmann, Y Zhang, ...

Science 370 (6515), eabd4585, 2020

Exigences : US Department of Defense, US National Institutes of Health, Howard Hughes …

[HTML] science.org

Autoantibodies neutralizing type I IFNs are present in~ 4% of uninfected individuals over 70 years old and account for~ 20% of COVID-19 deaths

P Bastard, A Gervais, T Le Voyer, J Rosain, Q Philippot, J Manry, ...

Science immunology 6 (62), eabl4340, 2021

Exigences : US National Institutes of Health, Howard Hughes Medical Institute, National …

An immune-based biomarker signature is associated with mortality in COVID-19 patients

MS Abers, OM Delmonte, EE Ricotta, J Fintzi, DL Fink, AAA de Jesus, ...

JCI insight 6 (1), e144455, 2021

Exigences : US National Institutes of Health, Government of Italy

[HTML] nature.com

Immunopathological signatures in multisystem inflammatory syndrome in children and pediatric COVID-19

K Sacco, R Castagnoli, S Vakkilainen, C Liu, OM Delmonte, C Oguz, ...

Nature medicine 28 (5), 1050-1062, 2022

Exigences : US Department of Defense, US National Institutes of Health, Government of Italy

Hematopoietic stem cell transplantation in primary immunodeficiency diseases: current status and future perspectives

R Castagnoli, OM Delmonte, E Calzoni, LD Notarangelo

Frontiers in pediatrics 7, 295, 2019

Exigences : US National Institutes of Health

[PDF] pnas.org

The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies

J Manry, P Bastard, A Gervais, T Le Voyer, J Rosain, Q Philippot, ...

Proceedings of the National Academy of Sciences 119 (21), 2022

Exigences : Fundação de Amparo à Pesquisa do Estado de São Paulo, US National Institutes …

Inborn errors of immunity with immune dysregulation: from bench to bedside

OM Delmonte, R Castagnoli, E Calzoni, LD Notarangelo

Frontiers in pediatrics 7, 353, 2019

Exigences : US National Institutes of Health

Neutralizing type‐I interferon autoantibodies are associated with delayed viral clearance and intensive care unit admission in patients with COVID‐19

MS Abers, LB Rosen, OM Delmonte, E Shaw, P Bastard, L Imberti, ...

Immunology and cell biology 99 (9), 917-921, 2021

Exigences : US National Institutes of Health, Howard Hughes Medical Institute, Institut …

[HTML] rupress.org

Autoantibodies against type I IFNs in patients with critical influenza pneumonia

Q Zhang, A Pizzorno, L Miorin, P Bastard, A Gervais, T Le Voyer, L Bizien, ...

Journal of Experimental Medicine 219 (11), e20220514, 2022

Exigences : US National Institutes of Health, Howard Hughes Medical Institute, Research …

[HTML] nature.com

Autoantibodies against type I IFNs in humans with alternative NF-κB pathway deficiency

T Le Voyer, AV Parent, X Liu, A Cederholm, A Gervais, J Rosain, ...

Nature 623 (7988), 803-813, 2023

Exigences : US National Institutes of Health, Howard Hughes Medical Institute, National …

Comprehensive genetic results for primary immunodeficiency disorders in a highly consanguineous population

W Al-Herz, J Chou, OM Delmonte, MJ Massaad, W Bainter, R Castagnoli, ...

Frontiers in immunology 9, 3146, 2019

Exigences : US National Institutes of Health, German Research Foundation, Knut and Alice …

[PDF] nih.gov

Cysteine and hydrophobic residues in CDR3 serve as distinct T-cell self-reactivity indices

SR Daley, HF Koay, K Dobbs, M Bosticardo, RC Wirasinha, F Pala, ...

The Journal of allergy and clinical immunology 144 (1), 333, 2019

Exigences : US National Institutes of Health, National Health and Medical Research …

[HTML] wiley.com

A compilation answering 50 questions on monkeypox virus and the current monkeypox outbreak

B Cabanillas, G Murdaca, A Guemari, MJ Torres, AK Azkur, E Aksoy, ...

Allergy 78 (3), 639-662, 2023

Exigences : Fonds national suisse, German Research Foundation, Government of Spain …

[HTML] wiley.com

Prognostic value of serum/plasma neurofilament light chain for COVID‐19‐associated mortality

RR Masvekar, P Kosa, K Jin, K Dobbs, MA Stack, R Castagnoli, ...

Annals of Clinical and Translational Neurology 9 (5), 622-632, 2022

Exigences : US National Institutes of Health, Government of Italy

Autoantibodies against proteins previously associated with autoimmunity in adult and pediatric patients with COVID-19 and children with MIS-C

PD Burbelo, R Castagnoli, C Shimizu, OM Delmonte, K Dobbs, ...

Frontiers in Immunology 13, 841126, 2022

Exigences : US National Institutes of Health, Government of Italy

[PDF] physiology.org

COVID-19 and inborn errors of immunity

OM Delmonte, R Castagnoli, LD Notarangelo

Physiology 37 (6), 290-301, 2022

Exigences : US National Institutes of Health

BTK inhibitors for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): a systematic review

M Stack, K Sacco, R Castagnoli, AA Livinski, LD Notarangelo, ...

Clinical Immunology 230, 108816, 2021

Exigences : US National Institutes of Health

Multicenter analysis of neutrophil extracellular trap dysregulation in adult and pediatric COVID-19

C Carmona-Rivera, Y Zhang, K Dobbs, TE Markowitz, CL Dalgard, ...

medRxiv, 2022

Exigences : US Department of Defense, US National Institutes of Health, Government of Italy

[HTML] mdpi.com

Gut microbiota–host interactions in inborn errors of immunity

R Castagnoli, F Pala, M Bosticardo, A Licari, OM Delmonte, A Villa, ...

International Journal of Molecular Sciences 22 (3), 1416, 2021

Exigences : US National Institutes of Health